Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
PRISM PHARMACEUTICALS
🇵🇰
Pakistan
Country
🇵🇰
Pakistan
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
A Randomized, Placebo-Controlled, Double-Blind, Double Dummy Trial To Determine The Relative Effect Of Pm101 Versus Placebo And Amiodarone IV On Blood Pressure In Subjects With Stable Congestive Heart Failure
Phase 2
Withdrawn
Conditions
Blood Pressure
Interventions
Drug: amiodarone
Subscribe
First Posted Date
2008-08-21
Last Posted Date
2017-09-11
Lead Sponsor
Prism Pharmaceuticals
Registration Number
NCT00739193
Subscribe
A Trial to Determine the Relative Effect of PM101 I.V. Versus Placebo on Hemodynamics in Healthy Adult Volunteers
Phase 1
Completed
Conditions
Healthy
Subscribe
First Posted Date
2007-07-17
Last Posted Date
2017-09-08
Lead Sponsor
Prism Pharmaceuticals
Target Recruit Count
342
Registration Number
NCT00502346
Locations
🇨🇦
Anapharm, Montreal, Quebec, Canada
Subscribe
Relative Bioavailability of PM101 IV and Cordarone IV
Phase 1
Completed
Conditions
Healthy
Subscribe
First Posted Date
2007-01-11
Last Posted Date
2017-09-08
Lead Sponsor
Prism Pharmaceuticals
Registration Number
NCT00420953
Locations
🇨🇦
Anapharm, Montreal, Quebec, Canada
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy